Boston Scientific Corporation was founded in 1979 and is headquartered in Marlborough, US

Report incorrect company information

Chairman and Chief Executive Officer

Report incorrect company information

Boston Scientific Corporation has offices in Sandton, Üsküdar, Gurugram, Maple Grove and in 7 other locations

Marlborough, US (HQ)

100 Boston Scientific Way

Arden Hills, US

4100 Hamline Ave N

Maple Grove, US

1 Scimed Pl

Huangpu Qu, CN

Meng Zi Lu

Voisins-le-Bretonneux, FR

2 Rue René Caudron

Gurugram, IN

48 Sohna Rd

Report incorrect company information

Boston Scientific Corporation's revenue was reported to be $8.39 b in FY, 2016 which is a **12.2% increase** from the previous period.

USD | |
---|---|

## Revenue (Q2, 2017) | 2.3 b |

## Gross profit (Q2, 2017) | 1.6 b |

## Gross profit margin (Q2, 2017), % | 72% |

## Net income (Q2, 2017) | 146 m |

## EBIT (Q2, 2017) | 225 m |

## Market capitalization (18-Apr-2018) | 40.3 b |

## Cash (30-Jun-2017) | 195 m |

## EV | 44.9 b |

Boston Scientific Corporation's current market capitalization is $40.3 b.

- Source: SEC Filings

Annual

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|---|

## Revenue | 7.1 b | 7.4 b | 7.5 b | 8.4 b |

| 3% | 1% | 12% | |

## Cost of goods sold | 2.2 b | 2.2 b | 2.2 b | 2.4 b |

## Gross profit | 5 b | 5.2 b | 5.3 b | 6 b |

Quarterly

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|

## Revenue | 1.7 b | 1.8 b | 1.9 b | 1.8 b | 1.8 b | 1.8 b | 1.9 b | 2 b | 2.1 b | 2.1 b | 2.2 b | 2.3 b |

## Cost of goods sold | 510 m | 537 m | 563 m | 550 m | 520 m | 540 m | 539 m | 573 m | 639 m | 594 m | 650 m | 632 m |

## Gross profit | 1.2 b | 1.2 b | 1.3 b | 1.3 b | 1.2 b | 1.3 b | 1.3 b | 1.4 b | 1.5 b | 1.5 b | 1.5 b | 1.6 b |

| 71% | 70% | 70% | 70% | 71% | 71% | 71% | 71% | 70% | 72% | 70% | 72% |

- Source: SEC Filings

Annual

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|---|

## Cash | 217 m | 587 m | 319 m | 196 m |

## Inventories | 897 m | 946 m | 1 b | 955 m |

## Current Assets | 3 b | 3.6 b | 3.5 b | 3.2 b |

## PP&E | 1.5 b | 1.5 b | 1.5 b | 1.6 b |

Quarterly

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|

## Cash | 571 m | 191 m | 357 m | 246 m | 242 m | 903 m | 350 m | 338 m | 438 m | 237 m | 156 m | 195 m |

## Accounts Receivable | 1.2 b | 1.2 b | 1.3 b | 1.2 b | 1.2 b | 1.2 b | 1.3 b | 1.3 b | 1.4 b | 1.4 b | 1.4 b | 1.4 b |

## Inventories | 895 m | 926 m | 949 m | 989 m | 958 m | 968 m | 1.1 b | 1 b | 981 m | 998 m | 971 m | 1 b |

## Current Assets | 3.5 b | 2.9 b | 3.2 b | 3.2 b | 3.2 b | 3.8 b | 3.5 b | 3.2 b | 3.3 b | 3.2 b | 3 b | 3.2 b |

Annual

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|---|

## Net Income | (121 m) | (119 m) | (239 m) | 347 m |

## Inventories | (7 m) | (81 m) | 3 m | 40 m |

## Accounts Payable | (37 m) | 620 m | (20 m) | 553 m |

## Cash From Operating Activities | 1.1 b | 1.3 b | 600 m | 972 m |

Quarterly

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 |
---|---|---|---|---|---|

## Net Income | (5 m) | 133 m | 4 m | 43 m | (1 m) |

USD | Y, 2017 |
---|---|

## EV/EBIT | 199.7 x |

## Revenue/Employee | 83.6 k |

## Financial Leverage | 2.5 x |

Boston Scientific Corporation's Customers was reported to be 35 k in FY, 2016.

FY, 2016 | |
---|---|

## Countries | 120 |

## Customers | 35 k |

## Facilities | 13 |

Acquired Company | Date | Deal Size |
---|---|---|

nVision Medical | April 12, 2018 | $275 m |

Symetis | March 30, 2017 | $435 m |

Report incorrect company information

December 28, 2017

WiseGuyReports.com adds “Global Remote Patient Monitoring Devices Market Professional Survey Report 2017” reports to its Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Report incorrect company information